Literature DB >> 29368965

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2018 EXECUTIVE SUMMARY.

Alan J Garber, Martin J Abrahamson, Joshua I Barzilay, Lawrence Blonde, Zachary T Bloomgarden, Michael A Bush, Samuel Dagogo-Jack, Ralph A DeFronzo, Daniel Einhorn, Vivian A Fonseca, Jeffrey R Garber, W Timothy Garvey, George Grunberger, Yehuda Handelsman, Irl B Hirsch, Paul S Jellinger, Janet B McGill, Jeffrey I Mechanick, Paul D Rosenblit, Guillermo E Umpierrez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29368965     DOI： 10.4158/CS-2017-0153

Source DB:  PubMed          Journal:  Endocr Pract        ISSN： 1530-891X            Impact factor:   3.443


× No keyword cloud information.
  146 in total

Review 1.  Glucose-Lowering Therapies for Cardiovascular Risk Reduction in Type 2 Diabetes Mellitus: State-of-the-Art Review.

Authors:  Salvatore Carbone; Dave L Dixon; Leo F Buckley; Antonio Abbate
Journal:  Mayo Clin Proc       Date:  2018-11       Impact factor: 7.616

2.  Severe Hypoglycemia Attributable to Intensive Glucose-Lowering Therapy Among US Adults With Diabetes: Population-Based Modeling Study, 2011-2014.

Authors:  Grace K Mahoney; Henry J Henk; Rozalina G McCoy
Journal:  Mayo Clin Proc       Date:  2019-08-15       Impact factor: 7.616

3.  Pharmacological Agents Utilized in Patients With Type-2 Diabetes: Beyond Lowering A1c.

Authors:  Joanna W Chung; Melody L Hartzler; Ashley Smith; Jessica Hatton; Kristi Kelley
Journal:  P T       Date:  2018-04

4.  Reporting quality of 2014-2018 clinical practice guidelines on diabetes according to the RIGHT checklist.

Authors:  Qianmei Wang; Yuting Duan; Jielin Liang; Ze Chen; Juexuan Chen; Yan Zheng; Yaolong Chen; Chunzhi Tang
Journal:  Endocrine       Date:  2019-07-16       Impact factor: 3.633

5.  How do these 3 diabetes agents compare in reducing mortality?

Authors:  Jennifer Martini; Catherine L Coe; Anne Mounsey
Journal:  J Fam Pract       Date:  2019-03       Impact factor: 0.493

Review 6.  Are low-carbohydrate diets safe in diabetic and nondiabetic chronic kidney disease?

Authors:  Nia S Mitchell; Julia J Scialla; William S Yancy
Journal:  Ann N Y Acad Sci       Date:  2019-01-15       Impact factor: 5.691

7.  Association of Second-line Antidiabetic Medications With Cardiovascular Events Among Insured Adults With Type 2 Diabetes.

Authors:  Matthew J O'Brien; Susan L Karam; Amisha Wallia; Raymond H Kang; Andrew J Cooper; Nicola Lancki; Margaret R Moran; David T Liss; Theodore A Prospect; Ronald T Ackermann
Journal:  JAMA Netw Open       Date:  2018-12-07

8.  Deintensification of Diabetes Medications among Veterans at the End of Life in VA Nursing Homes.

Authors:  Joshua D Niznik; Jacob N Hunnicutt; Xinhua Zhao; Maria K Mor; Florentina Sileanu; Sherrie L Aspinall; Sydney P Springer; Mary J Ersek; Walid F Gellad; Loren J Schleiden; Joseph T Hanlon; Joshua M Thorpe; Carolyn T Thorpe
Journal:  J Am Geriatr Soc       Date:  2020-02-17       Impact factor: 5.562

9.  Predicting complications of diabetes mellitus using advanced machine learning algorithms.

Authors:  Branimir Ljubic; Ameen Abdel Hai; Marija Stanojevic; Wilson Diaz; Daniel Polimac; Martin Pavlovski; Zoran Obradovic
Journal:  J Am Med Inform Assoc       Date:  2020-07-01       Impact factor: 4.497

10.  Effect of diabetes self-management education on glycemic control in Latino adults with type 2 diabetes: A systematic review and meta-analysis.

Authors:  Janett A Hildebrand; John Billimek; Jung-Ah Lee; Dara H Sorkin; Ellen F Olshansky; Stephen L Clancy; Lorraine S Evangelista
Journal:  Patient Educ Couns       Date:  2019-09-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.